Pressmeddelanden

Coegin Pharma receives first purchase order for new scalp serum Coegin Pharma AB ("Coegin" or the "Company") today announces that it has received its first limited purchase order for the Company's newly introduced high-performance cosmetic sc...
Coegin Pharma accelerates Follicopeptide® portfolio expansion with a new high-performance scalp serum Coegin Pharma AB ("Coegin") today announces further details on the launch of a new high-performance cosmetic scalp serum developed to optimize the scalp environment. The product...
REG
Coegin Pharma AB (publ) publishes its year-end report for 2025 Summary of year-end report 2025With products on the market, strengthened financing and a growing platform strategy, Coegin Pharma enters 2026 from a significantly stronger positi...
REG MAR
Coegin Pharma carries out directed issues totalling approx. SEK 12.1 million and strengthens the Company's liquidity position The Board of Directors of Coegin Pharma AB (publ) (the "Company" or "Coegin Pharma") has today resolved to carry out directed issues totalling up to approximately SEK 12.1 millio...
Coegin Pharma provides an operational and strategic update Coegin Pharma AB ("Coegin" or the "Company") today provides an operational and strategic update regarding its commercialization activities and business planning. Operational upda...
Coegin Pharma appoints worldleading pigmentation and hair-biology expert Professor Desmond J. Tobin as Scientific Advisor Coegin Pharma AB ("Coegin") is delighted to announce that Professor Desmond J. Tobin, a globally recognized leader in skin and hair pigmentation science and hair-follicle biology...
Visa fler pressmeddelanden

Rapporter

Datum Rubrik
Year-End Report 2025
Interim Report Q3 2025
Quarterly report Q2

Video

Finansiell kalender

Om Coegin Pharma

Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.

Webbplats
www.coeginpharma.com
Bransch
Bioteknik

Prenumerera

Få löpande information från Coegin Pharma via e-post.

Språk
Nyhetstyper

Handelsinformation

Kurs 3,71 SEK (2026-03-06)
Förändring −14,32% (2025-03-06)
Marknad NGM Nordic SME Kortnamn COEGIN ISIN-kod SE0020357754

IR-Kontakt

Jens Eriksson vd [email protected]